Sec Form 4 Filing - Schwartz Carl I. @ Predictive Oncology Inc. - 2020-09-04

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Schwartz Carl I. 2. Issuer Name and Ticker or Trading Symbol Predictive Oncology Inc. [ POAI] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X __ Director X __ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Executive Officer (Last) (First) (Middle) 3750 LAS VEGAS BLVD. SOUTH, APT. 4303 3. Date of Earliest Transaction (MM/DD/YY) 09/04/2020 (Street) LAS VEGAS, NV89158 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 1,611,981 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Options (right to buy) $ 775 09/04/2020 D( 1 ) 52 ( 2 ) 06/30/2025 Common Stock 52 $ 0 0 D ( 3 ) Stock Options (Right to buy) $ 1.54 09/04/2020 A( 1 ) 52 ( 2 ) 06/30/2025 Common Stock 52 $ 0 52 D ( 3 ) Stock Options (Right to buy) $ 28 09/04/2020 D( 1 ) 714 ( 2 ) 12/31/2026 Common Stock 714 $ 0 0 D ( 3 ) Stock Options (Right to buy) $ 1.54 09/04/2020 A( 1 ) 714 ( 2 ) 12/31/2026 Common Stock 714 $ 0 714 D ( 3 ) Stock Options (Right to buy) $ 14.7 09/04/2020 D( 1 ) 37,691 ( 2 ) 06/22/2027 Common Stock 37,691 $ 0 0 D ( 3 ) Common Stock (Right to buy) $ 1.54 09/04/2020 A( 1 ) 37,691 ( 2 ) 06/22/2027 Common Stock 37,691 $ 0 37,691 D ( 3 ) Stock Options (Right to buy) $ 14.7 09/04/2020 D( 1 ) 2,834 ( 2 ) 11/10/2027 Common Stock 2,834 $ 0 0 D ( 3 ) Stock Options (Right to buy) $ 1.54 09/04/2020 A( 1 ) 2,834 ( 2 ) 11/10/2027 Common Stock 2,834 $ 0 2,834 D ( 3 ) Stock Options (Right to buy) $ 9.7 09/04/2020 D( 1 ) 14,178 ( 2 ) 01/02/2028 Common Stock 14,178 $ 0 0 D ( 3 ) Stock Options (Right to buy) $ 1.54 09/04/2020 A( 1 ) 14,178 ( 2 ) 01/02/2028 Common Stock 14,178 $ 0 14,178 D ( 3 ) Stock Options (Right to buy) $ 11.3 09/04/2020 D( 1 ) 12,168 ( 2 ) 06/30/2028 Common Stock 12,168 $ 0 0 D ( 3 ) Common Stock (Right to buy) $ 1.54 09/04/2020 A( 1 ) 12,168 ( 2 ) 06/30/2028 Common Stock 12,168 $ 0 12,168 D ( 3 ) Stock Options (Right to buy) $ 11.6 09/04/2020 D( 1 ) 4,490 ( 2 ) 08/01/2028 Common Stock 4,490 $ 0 0 D ( 3 ) Stock Options (Right to buy) $ 1.54 09/04/2020 A( 1 ) 4,490 ( 2 ) 08/01/2028 Common Stock 4,490 $ 0 4,490 D ( 3 ) Stock Options (Right to buy) $ 6.191 09/04/2020 D( 1 ) 32,305 ( 2 ) 01/02/2029 Common Stock 32,305 $ 0 0 D ( 3 ) Stock Options (Right to buy) $ 1.54 09/04/2020 A( 1 ) 32,305 ( 2 ) 01/02/2029 Common Stock 32,305 $ 0 32,305 D ( 3 ) Stock Options (Right to buy) $ 2,812.5 09/04/2020 D( 1 ) 7 ( 2 ) 07/19/2023 Common Stock 7 $ 0 0 D ( 3 ) Stock Options (Right to buy) $ 1.54 09/04/2020 A( 1 ) 7 ( 2 ) 07/19/2023 Common Stock 7 $ 0 7 D Stock Options (Right to buy) $ 21 09/04/2020 D( 1 ) 238 ( 2 ) 03/31/2027 Common Stock 238 $ 0 0 D ( 3 ) Stock Options (Right to buy) $ 1.54 09/04/2020 A( 1 ) 238 ( 2 ) 03/31/2027 Common Stock 238 $ 0 238 D ( 3 ) Stock Options (Right to buy) $ 28 09/04/2020 D( 1 ) 179 ( 2 ) 12/31/2026 Common Stock 179 $ 0 0 D ( 3 ) Stock Options (Right to buy) $ 1.54 09/04/2020 A( 1 ) 179 ( 2 ) 12/31/2026 Common Stock 179 $ 0 179 D ( 3 ) Stock Options (Right to buy) $ 41.25 09/04/2020 D( 1 ) 121 ( 2 ) 09/30/2026 Common Stock 121 $ 0 0 D ( 3 ) Stock Options (Right to buy) $ 1.54 09/04/2020 A( 1 ) 121 ( 2 ) 09/30/2026 Common Stock 121 $ 0 121 D ( 3 ) Stock Options (Right to buy) $ 37.5 09/04/2020 D( 1 ) 133 ( 2 ) 06/30/2026 Common Stock 133 $ 0 0 D ( 3 ) Stock Options (Right to buy) $ 1.54 09/04/2020 A( 1 ) 133 ( 2 ) 06/30/2026 Common Stock 133 $ 0 133 D ( 3 ) Stock Options (Right to buy) $ 42.5 09/04/2020 D( 1 ) 59 ( 2 ) 03/31/2026 Common Stock 59 $ 0 0 D ( 3 ) Stock Options (Right to buy) $ 1.54 09/04/2020 A( 1 ) 59 ( 2 ) 03/31/2026 Common Stock 59 $ 0 59 D ( 3 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Schwartz Carl I. 3750 LAS VEGAS BLVD. SOUTH APT. 4303 LAS VEGAS, NV89158 X X Chief Executive Officer Signatures /s/ Carl I. Schwartz, DDS 09/09/2020 Signature of Reporting Person Date

Explanation of Responses:

( 1 )All transactions reported on this form involve the repricing of stock options with an exercise price greater than $1.54 to an exercise price of $1.54, as approved by shareholders at the 2020 annual meeting, with certification of the shareholder vote as of September 4, 2020. ( 2 )Currently exercisable. ( 3 )Held by the Carl I. Schwartz Revocable Living Trust

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.